Related Experiment Video
Updated: Mar 8, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Simplified mitral valve repair in pediatric patients with connective tissue disorders
Luca A Vricella1, William A Ravekes1, Eloisa Arbustini2
1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Md.
Insights
A simplified surgical repair effectively treats severe mitral regurgitation in pediatric patients with connective tissue disorders, preventing complications and reducing heart enlargement. This approach offers intermediate-term competence and positive cardiac remodeling.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Connective Tissue Disorders
Background:
- Pediatric patients with connective tissue disorders (CTDs) often present with severe mitral regurgitation (MR) and bileaflet prolapse.
- Aortic root enlargement is a less common cardiac manifestation in this population.
- Systolic anterior motion (SAM) is a potential complication that needs to be addressed.
Purpose of the Study:
- To evaluate the efficacy of a simplified surgical repair for severe MR in pediatric patients with CTDs.
- To assess the prevention of SAM and other complications associated with this repair technique.
- To determine the intermediate-term outcomes and cardiac remodeling following the simplified repair.
Main Methods:
- Retrospective review of clinical and echocardiographic data from pediatric patients (age < 18 years) with CTD and MR.
- Analysis of data from three institutions between 2000 and 2014.
- Patients underwent a simplified repair involving ring annuloplasty and Alfieri edge-to-edge repair.
Main Results:
- Eighteen pediatric patients with CTD and severe MR underwent the simplified repair.
- The procedure was associated with a low mortality rate (5.6%) and no other major complications.
- At a median follow-up of 2.4 years, 94.4% of survivors had mild or less regurgitation, with no SAM or significant stenosis.
- Left ventricular dimensions regressed significantly post-repair.
Conclusions:
- A simplified surgical approach is effective for managing severe MR in pediatric patients with CTDs.
- This technique achieves intermediate-term mitral valve competence and prevents adverse events like SAM.
- The simplified repair promotes regression of left ventricular enlargement in this patient cohort.
Background:
In pediatric patients with connective tissue disorders (CTDs), early cardiac presentation often involves severe mitral regurgitation (MR) associated with severe bileaflet prolapse and, less frequently, aortic root enlargement. We adopted a simplified repair to address MR and prevent systolic anterior motion (SAM) in this unique group of patients.
Materials And Methods:
Retrospective review of clinical and echocardiographic data of all pediatric patients (age < 18 years) with CTD and MR undergoing simplified repair at 3 institutions (2000-2014).
Results:
Eighteen children who underwent surgery for severe MR and bileaflet prolapse were identified. All were treated with ring annuloplasty and Alfieri edge-to-edge repair. Median age and weight were 8.2 years (range, 0.4-17.2 years) and 24.9 kg (5.6-63.3 kg), respectively. Median left ventricular end diastolic dimension median z score was 4.9 (2.1-11.9). One patient died (5.6%), and there were no other major complications. Among survivors, 94.4% had mild regurgitation or less, with no stenosis or SAM at median clinical follow-up of 2.4 years (range, 0-13.9 years). Median left ventricular end-diastolic dimension z score regressed to 1.3 (-0.5 to 4.3).
Conclusions:
In pediatric patients with CTD and severe MR, a simplified approach is associated with intermediate-term competence, absence of SAM or significant stenosis, and regression of left ventricular enlargement.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

